SAN FRANCISCO, Aug. 3, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, is pleased to announce that President and CEO David Passov has been named one of the 100 most inspiring people in the life-sciences industry by PharmaVOICE magazine.
According to the editors at PharmaVOICE, "Recognizing the importance of emerging nations in improving recruitment for clinical trials, David Passov has been educating the industry about the huge potential open to it within Russia, Ukraine, Belarus and the Baltics. Mr. Passov works hard to dispel any rumors or myths about these markets, noting that the clear advantage of conducting clinical trials in markets such as Russia is that companies can enroll patients three to 20 times faster than in the United States and Western Europe." In a recent interview with NPR, Mr. Passov "helped convey how ongoing drug research in Russia benefits the general population by providing quicker access to advanced healthcare that may otherwise not be available for years or ever at all."
"I am honored to receive this distinguished recognition from PharmaVOICE. It is a satisfying affirmation of the work we are doing in conjunction with the biopharmaceutical industry in the region, and ultimately, the positive impact we are having on bringing more advance healthcare to the people of Russia and Eastern Europe," says Mr. Passov.
Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers and represent a broad cross section of industry sectors. Those chosen contribute to the growth and well-being of their individual companies, their communities and varied industry associations.
About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics, with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of nearly 300 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.
|SOURCE ClinStar, LLC|
Copyright©2010 PR Newswire.
All rights reserved